# Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

> **NCT01676688** · — · COMPLETED · sponsor: **Laboratoire français de Fractionnement et de Biotechnologies** · enrollment: 17 (actual)

## Conditions studied

- Alpha 1-Antitrypsin Deficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01676688
- **Lead sponsor:** Laboratoire français de Fractionnement et de Biotechnologies
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-09
- **Final completion:** 2012-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01676688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01676688, "Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01676688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*